The Ebola crisis in DR Congo has entered a more dangerous phase, with the Ebola outbreak now spreading to a fourth province.
India's Pharma Exports are entering a new phase as drugmakers expand beyond their biggest market, the US, to tap fresh opportunities in Brazil.
Alembic marks another milestone in securing approval from the USFDA for Dapsone Gel, which is a treatment for acne vulgaris, a skin disorder. Alembic marks this as an achievement, which turns them on to the US market
The global diabetes clinical trials market is on a steady upward trajectory, projected to grow from USD 5.45 billion in 2026 to USD 10.02 billion by 2034, at a CAGR of 7.9 percent, according to a comprehensive new industry analysis.
India has taken another step to tackle Anaemia by expanding its flagship Anaemia Mukt Bharat programme.
Haryana has initiated a project under the Pharmaceuticals and Medical Devices Manufacturing Policy 2026, which attracts 10,000 crore in investment and 20,000 job opportunities, thereby making Haryana a unique state in coming up with likely projects
Medical Device Licences could soon become easier and quicker to obtain in India, a move that may do more than reduce paperwork.
AI could soon become one of the strongest tools to help doctors prevent cervical cancer before it develops.
Aurobindo Pharma's API Plant Clears FDA Review With Minor Findings as the company received only two observations from the US Food and Drug Administration (USFDA) following an inspection of one of its API plant facilities.
.jpg "India May Scrap 60 percent Shelf Life Rule for Imported Drugs")
The Imported Drug Shelf Life Rule could soon see a major change in India. The Central government has proposed scrapping the existing 60 percent residual shelf life requirement for imported medicines and replacing it with a simpler 12-month rule.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")